PubRank

Beverly Moy

Author PubWeight™ 33.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. J Clin Oncol 2005 2.09
2 Institutional academic industry relationships. JAMA 2007 2.05
3 Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med 2015 1.76
4 Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial. Lancet Oncol 2012 1.75
5 Mammographic screening: patterns of use and estimated impact on breast carcinoma survival. Cancer 2004 1.66
6 Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction. J Clin Oncol 2009 1.61
7 Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology 2007 1.42
8 Mammographic breast density and race. AJR Am J Roentgenol 2007 1.35
9 Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib. Clin Cancer Res 2011 1.31
10 Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study. Breast Cancer Res 2012 1.26
11 Postmenopausal hormone use and symptoms of gastroesophageal reflux. Arch Intern Med 2008 1.18
12 Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery. BMC Med Inform Decis Mak 2012 1.14
13 Is there a role for decision aids in advanced breast cancer? Med Decis Making 2009 1.10
14 Lapatinib. Nat Rev Drug Discov 2007 1.10
15 Doctor-patient communication about advance directives in metastatic breast cancer. J Palliat Med 2009 1.01
16 Institutional academic industry relationship: results of interviews with university leaders. Account Res 2005 1.00
17 Decision making about surgery for early-stage breast cancer. J Am Coll Surg 2011 0.96
18 Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article]. Plast Reconstr Surg 2011 0.96
19 A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases. Breast Cancer Res Treat 2013 0.93
20 Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea. J Clin Oncol 2010 0.91
21 Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapy. BMC Med Inform Decis Mak 2014 0.89
22 Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing. Qual Life Res 2010 0.86
23 Patient navigation for underserved patients diagnosed with breast cancer. Oncologist 2012 0.83
24 Ethical considerations for the clinical oncologist in an era of oncology drug shortages. Oncologist 2014 0.79
25 Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapy. Int J Biol Markers 2013 0.79
26 Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial). Breast Cancer Res Treat 2015 0.78
27 The cost of cancer care--balancing our duties to patients versus society: are they mutually exclusive? Oncologist 2013 0.76
28 Case records of the Massachusetts General Hospital. Case 1-2015. A 66-year-old woman with metastatic breast cancer after endocrine therapy. N Engl J Med 2015 0.76
29 Ethical challenges: caring for the underinsured, geographically disadvantaged patient. J Oncol Pract 2012 0.75
30 Massachusetts general hospital: improving patient access to the breast oncology clinic. J Natl Compr Canc Netw 2014 0.75
31 Cancer health disparities and the cost of cancer care: payment model issues. J Natl Compr Canc Netw 2013 0.75